Moderna, Merck see positive results from skin cancer vaccine

  • 📰 gmanews
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 68%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The Moderna and Merck drug makers on Tuesday announced positive results from a trial in which messenger RNA technology was used for the first time to make personalized vaccines for skin cancer patients.

The mRNA technology proved vital in the development of vaccines against COVID-19, and scientists have long believed it could help fight other viruses and diseases like cancer.

"Today's results are highly encouraging for the field of cancer treatment," Moderna's Chief Executive Officer Stephane Bancel, said in a statement. Messenger RNA is a molecule within cells that carries instructions to form proteins. Scientists can design them to make a particular protein in the body that can help fight viruses and other illnesses.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in LAW

Law Law Latest News, Law Law Headlines